References
1 Borm, PJA, Robbins, D, Haubold, S, Kuhlbusch, T, Fissan, H, Donaldson, K, Schins, R, Stone, V, Keyling, W, Lademann, J, et al. The potential risk of nanomaterials: a review carried out for ECETOC. Particle Fibre Toxicol 2006, 3:11.
2 SCENIHR report 002/05. Opinion on: The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies (September 28–29, 2005).
3 Berube, DM. Rhetorical gamesmanship in the nano debates over sunscreens and nanoparticles. J Nanopart Res 2008, 10:23–37.
4 Jonaitis, TS, Card, JW, Magnuson, B. Concerns regarding nano‐sized titanium dioxide dermal penetration and toxicity study. Toxicol Lett 2010, 192:268–269.
5 Auffan, , M, Rose, J, Bottero, J‐Y, Lowry, GV, Jolivet, J‐P, Wiesner, MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nature Nanotechnol 2009, 4:634–641.
6 Foss Hansen, S, Larsen, BH, Olsen, SI, Baun, A. Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 2007, 1:243–250.
7 Lowe, NJ, Shaath, NA, Pathak, MA, eds. Sunscreens: Development, Evaluation, and Regulatory Aspects. New York:
Marcel Dekker; 1997.
8 Popov, AP, Lademann, J, Priezzhev, AV, Myllylä, R. Effect of size of TiO
2 nanoparticles embedded into
stratum corneum on ultraviolet‐A and ultraviolet‐B sun‐blocking properties of the skin. J Biomed Opt 2005, 10:064037.
9 Arshady, R, ed. Micropheres, Microcapsules, %26 Liposomes. Vol. 1. London:
Citus Books; 1999.
10 Xiang, SD, Selomulya, C, Ho, J, Apostolopoulos, V, Plebanski, M. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. WIREs Nanomed Nanobiotechnol 2010, 2:205–218.
11 Andrieux, K, Couvreur, P. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood‐brain barrier. WIREs Nanomed Nanobiotechnol 2009, 1:463–474.
12 McNeil, SE. Nanoparticle therapeutics: a personal perspective. WIREs Nanomed Nanobiotechnol 2009, 1:264–271.
13 Seale‐Goldsmith, M‐M, Leary, JF. Nanobiosystems. WIREs Nanomed Nanobiotechnol 2009, 1:553–567.
14 Benita, S, ed. Microencapsulation: Methods and Industrial Applications. New York:
Marcel Dekker; 1996.
15 Moinard‐Checot, D, Chevalier, Y, Briançon, S, Fessi, H, Guinebretière, S. Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion–diffusion process. J Nanosci Nanotechnol 2006, 6:2664–2681.
16 Müller, RH, Radtke, M, Wissing, SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002, 54(
suppl 1):S131–S155.
17 Müller, RH, Mäder, K, Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 2000, 50:161–177.
18 Garcia‐Fuentes, M, Alonso, MJ, Torres, D. Design and characterization of a new drug nanocarrier made from solid–liquid lipid mixtures. J Colloid Interface Sci 2005, 285:590–598.
19 Gregoriadis, G, ed. Liposome Technology.
3rd ed. New York:
Informa Healthcare; 2007.
20 New, RRC, ed. Liposomes: A Practical Approach. Oxford:
Oxford University Press; 1990.
21 Geraci, CL, Castranova, V. Challenges in assessing nanomaterial toxicology: a personal perspective. WIREs Nanomed Nanobiotechnol 2010, 2:569–577.
22 Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Internal Med 2010, 267:89–105.
23 Schaefer, H, Watts, F, Brod, J, Illel, B. %22Follicular penetration.%22 In: Scott, RC, Guy, RH, eds. Prediction of Percutaneous Penetration, Methods, Measurements, Modelling. London:
IBC Technical Services; 1990, 163–173.
24 Rolland, A, Wagner, N, Chatelus, A, Shroot, B, Schaefer, H. Site‐specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 1993, 10:1738–1744.
25 Ohulchanskyy, TY, Roy, I, Yong, K‐T, Pudavar, HE, Prasad, PN. High‐resolution light microscopy using luminescent nanoparticles. WIREs Nanomed Nanobiotechnol 2010, 2:162–175.
26 Zhang, LW, Yu, WW, Colvin, VL, Monteiro‐Riviere, NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 2008, 228:200–211.
27 Lee, HA, Imran, M, Monteiro‐Riviere, NA, Colvin, VL, Yu, WW, Riviere, JE. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007, 7:2865–2870.
28 Ryman‐Rasmussen, JP, Riviere, JE, Monteiro‐Riviere, NA. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett 2007, 7:1344–1348.
29 Tinkle, SS, Antonini, JM, Rich, BA, Roberts, JR, Salmen, R, DePree, K, Adkins, EJ. Environ Health Perspect 2003, 111:1202–1208.
30 Ryman‐Rasmussen, JP, Riviere, JE, Monteiro‐Riviere, NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006, 91:159–165.
31 Rouse, JG, Yang, J, Ryman‐Rasmussen, JP, Barron, AR, Monteiro‐Riviere, NA. Effects of mechanical flexion on the penetration of fullerene amino acid‐derivatized peptide nanoparticles through skin. Nano Lett 2007, 7:155–160.
32 Baroli, B, Ennas, MG, Loffredo, F, Isola, M, Pinna, R, López‐Quintela, MA. Penetration of metallic nanoparticles in human full‐thickness skin. J Invest Dermatol 2007, 127:1701–1712.
33 Mortensen, LJ, Oberdörster, G, Pentland, AP, DeLouise, LA.
In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008, 8:2779–2787.
34 Sonavane, G, Tomoda, K, Sano, A, Ohshima, H, Terada, H, Makino, K.
In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008, 65:1–10.
35 Filon Larese, F, D`Agostin, F, Crosera, M, Adami, G, Renzi, N, Bovenzi, M, Maina, G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33–37.
36 Graf, C, Meinke, M, Gao, Q, Hadam, S, Raabe, J, Sterry, W, Blume‐Peytavi, U, Lademann, J, Rühl, E, Vogt, A. Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission x‐ray microscopy. J Biomed Opt 2009, 14:021015.
37 Hemmerle, J, Msika, P, Gooris, E. An electron microscopical approach to efficacy screening of physical sunscreens. J Soc Cosmet Chem 1996, 47:59–72.
38 Dussert, A‐S, Gooris, E, Hemmerle, J. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human
stratum corneum. Int J Cosmet Sci 1997, 19:119–129.
39 Tan, M‐H, Commens, CA, Burnett, L, Snitch, PJ. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 1996, 37:185–187.
40 van der Molen, RG, Hurks, HMH, Out‐Luiting, C, Spies, F, van`t Noordende, JM, Koerten, HK, Mommaas, AM. Efficacy of micronized titanium dioxide‐containing compounds in protection against UVB‐induced immunosuppression in humans
in vivo. J Photochem Photobiol B 1998, 44:143–150.
41 Schulz, J, Hohenberg, H, Pflücker, F, Gärtner, E, Will, T, Pfeiffer, S, Wepf, R, Wendel, V, Gers‐Barlag, H, Wittern, K‐P. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002, 54(
suppl 1):S157–S163.
42 Pflücker, F, Hohenberg, H, Hölzle, E, Will, T, Pfeiffer, S, Wepf, R, Diembeck, W, Wenck, H, Gers‐Barlag, H. The outermost
stratum corneum layer is an effective barrier against dermal uptake of topically applied micronized titanium dioxide. Int J Cosmet Sci 1999, 21:399–411.
43 Pflücker, F, Wendel, V, Hohenberg, H, Gärtner, E, Will, T, Pfeiffer, S, Wepf, R, Gers‐Barlag, H. The human
stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol Appl Skin Physiol 2001, 14(
suppl 1):92–97.
44 Gamer, AO, Leibold, E, van Ravenzwaay, B. The
in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 2006, 20:301–307.
45 NANODERM. Quality of skin as a barrier to ultra‐fine particles. QLK4‐CT‐2002‐02678 Final Report.
46 Menzel, R, Reinert, T, Vogt, J, Butz, T. Investigations of percutaneous uptake of ultrafine TiO
2 particles at the high energy ion nanoprobe LIPSION. Nucl Instrum Methods Phys Res B 2004, 219–220:82–86.
47 Kertész, Zs, Szikszai, Z, Uzonyi, I, Simon, A, Kiss, ÁZ. Development of a bio‐PIXE setup at the Debrecen scanning proton microprobe. Nucl Instrum Methods Phys Res B 2005, 231:106–111.
48 Pallon, J, Garmer, M, Auzelyte, V, Elfman, M, Kristiansson, P, Malmqvist, K, Nilsson, C, Shariff, A, Marie Wegdén, M. Optimization of PIXE‐sensitivity for detection of Ti in thin human skin sections. Nucl Instrum Methods Phys Res B 2005, 231:274–279.
49 Kertész, Zs, Szikszai, Z, Gontier, E, Moretto, P, Surlève‐Bazeille, J‐E, Kiss, B, Juhász, I, Hunyadi, J, Kiss, ÁZ. Nuclear microprobe study of TiO
2‐penetration in the epidermis of human skin xenograft. Nucl Instrum Methods Phys Res B 2005, 231:280–285.
50 Aguer, P, Alves, LC, Barberet, P, Gontier, E, Incerti, S, Michelet‐Habchi, C, Kertész, Zs, Kiss, ÁZ, Moretto, P, Pallon, J, et al. Skin morphology and layer identification using different STIM geometries. Nucl Instrum Methods Phys Res B 2005, 231:292–299.
51 Lekki, J, Stachura, Z, Dabroś, W, Stachura, J, Menzel, F, Reinert, T, Butz, T, Pallon, J, Gontier, E, Ynsa, MD, et al. On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl Instrum Methods Phys Res B 2007, 260:174–177.
52 Pinheiro, T, Pallon, J, Alves, LC, Veríssimo, A, Filipe, P, Silva, JN, Silva, R. The influence of corneocyte structure on the interpretation of permeation profiles of nanoparticles across skin. Nucl Instrum Methods Phys Res B 2007, 260:119–123.
53 Gontier, E, Ynsa, M‐D, Bíró, T, Hunyadi, J, Kiss, B, Gáspár, K, Pinheiro, T, Silva, J‐N, Filipe, P, Stachura, J, et al. Is there penetration of titania nanoparticles in sunscreens through skin? A comparative electron and ion microscopy study. Nanotoxicology 2008, 2:218–231.
54 Filipe, P, Silva, JN, Silva, R, Cirne de Castro, JL, Marques Gomes, M, Alves, LC, Santus, R, Pinheiro, T.
Stratum corneum is an effective barrier to TiO
2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 2009, 22:266–275.
55 Mavon, A, Miquel, C, Lejeune, O, Payre, B, Moretto, P.
In vitro percutaneous absorption and
in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 2007, 20:10–20.
56 Wu, J, Liu, W, Xue, C, Zhou, S, Lan, F, Bi, L, Xu, H, Yang, X, Zeng, F‐D. Toxicity and penetration of TiO
2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 2009, 191:1–8.
57 Gulson, B, McCall, M, Korsch, M, Gomez, L, Casey, P, Oytam, Y, Taylor, A, McCulloch, M, Trotter, J, Kinsley, L, Greenoak, G. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 2010, 118:140–149.
58 Sadrieh, N, Wokovich, AM, Gopee, NV, Zheng, J, Haines, D, Parmiter, D, Siitonen, PH, Cozart, CR, Patri, AK, McNeil, SE, et al. Lack of significant dermal penetration of titanium dioxide (TiO
2) from sunscreen formulations containing nano‐ and sub‐micron‐size TiO
2 particles. Toxicol Sci 2010, 115:156–166.
59 Cappel, MJ, Kreuters, J. Effect of nanoparticles on transdermal drug delivery. J Microencapsulation 1991, 8:369–374.
60 de Jalón, EG, Blanco‐Príeto, MJ, Ygartua, P, Santoyo, S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001, 226:181–184.
61 Alvarez‐Román, R, Naik, A, Kalia, YN, Guy, RH, Fessi, H. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004, 99:53–62.
62 Alvarez‐Román, R, Naik, A, Kalia, YN, Fessi, H, Guy, RH. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm 2004, 58:301–316.
63 Toll, R, Jacobi, U, Richter, H, Lademann, J, Schaefer, H, Blume‐Peytavi, U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004, 123:168–176.
64 Wu, X, Price, GJ, Guy, RH. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol Pharm 2009, 6:1441–1448.
65 Müller, B, Kreuter, J. Enhanced transport of nanoparticles associated drugs through natural and artificial membranes ‐ a general phenomenon? Int J Pharm 1999, 178:23–32.
66 de Jalón, EG, Blanco‐Príeto, MJ, Ygartua, P, Santoyo, S. Topical application of acyclovir‐loaded microparticles: quantification of the drug in porcine skin layers. J Control Release 2001, 75:191–197.
67 Alvarez‐Román, R, Naik, A, Kalia, YN, Guy, RH, Fessi, H. Enhancement of topical delivery of a lipophilic drug from biodegradable nanoparticles. Pharm Res 2004, 21:1818–1825.
68 Jiménez, MM, Pelletier, J, Bobin, MF, Martini, MC. Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm 2004, 272:45–55.
69 Alvarez‐Román, R, Barre, G, Guy, RH, Fessi, H. Bio‐degradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 2001, 52:191–195.
70 Shim, J, Kang, HS, Park, W‐S, Han, S‐H, Kim, J, Chang, I‐S., Transdermal delivery of mixnoxidil in block‐copolymer nanoparticles. J Control Release 2004, 97:477–484.
71 Stracke, F, Weiss, B, Lehr, C‐M, König, K, Schaefer, UF, Schneider, M. Multiphoton microscopy for the investigation of dermal penetration of nanoparticle‐borne drugs. J Invest Dermatol 2006, 126:2224–2233.
72 Bourgeois, S, Bolzinger, MA, Pelletier, J, Valour, JP, Briançon, St. Caffeine microspheres—an attractive carrier for optimum skin penetration. IFSCC Mag 2009, 12:359–363.
73 Schäfer‐Korting, M, Mehnert, W, Korting, H‐C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007, 59:427–443.
74 Jennings, V, Schäfer‐Korting, M, Gohla, S. Vitamin A‐loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000, 66:115–126.
75 Souto, EB, Almeida, AJ, Müller, RH. Lipid nanoparticles (SLNˆ®, NLCˆ® for cutaneous drug delivery: Structure, protection and skin effects. J Biomed Nanotechnol 2007, 3:317–331.
76 Wissing, SA, Müller, RH. Solid lipid nanoparticles as carriers for sunscreens:
in vitro release and
in vivo skin penetration. J Control Release 2002, 81:225–233.
77 Souto, EB, Wissing, SA, Barbosa, CM, Müller, RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004, 278:71–77.
78 Fang, J‐Y, Fang, C‐L, Liu, C‐H, Su, Y‐H. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008, 70:633–640.
79 Lombardi‐Borgia, S, Regehly, M, Sivaramakrishnan, R, Mehnert, W, Korting, HC, Danker, K, Röder, B, Kramer, KD, Schäfer‐Korting, M. Lipid nanoparticles for skin penetration enhancement ‐ correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005, 110:151–163.
80 Küchler, S, Herrmann, W, Panek‐Minkin, G, Blaschke, T, Zoschke, C, Kramer, KD, Bittl, R, Schäfer‐Korting, M. SLN for topical application in skin diseases—characterization of drug–carrier and carrier–target interactions. Int J Pharm 2010, 390:225–233.
81 Jennings, V, Gysler, A, Schäfer‐Korting, M, Gohla, SH. Vitamin A‐loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000, 49:211–218.
82 Wissing, SA, Lippacher, A, Müller, RH. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 2001, 52:313–323.
83 Wissing, SA, Müller, RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity—
in vivo study. Eur J Pharm Biopharm 2003, 56:67–72.
84 Frelichowska, J, Bolzinger, M‐A, Valour, J‐P, Mouaziz, H, Pelletier, J, Chevalier, Y. Pickering w/o emulsions: drug release and topical delivery. Int J Pharm 2009, 368:7–15.
85 Frelichowska, J, Bolzinger, M‐A, Pelletier, J, Valour, J‐P, Chevalier, Y. Topical delivery of lipophilic drugs from o/w Pickering emulsions. Int J Pharm 2009, 371:56–63.
86 Egbaria, K, Weiner, N. Liposomes as a topical drug delivery system. Adv Drug Deliv Rev 1990, 5:287–300.
87 Elsayed, MMA, Abdallah, OY, Naggar, VF, Khalafallah, NM. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int J Pharm 2007, 332;1–16.
88 Lauer, AC, Ramachandran, C, Lieb, LM, Niemiec, S, Weiner, ND. Targeted delivery to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996, 18:311–324.
89 Weiner, N, Martin, F, Riaz, M. Liposomes as a drug delivery system. Drug Dev Ind Pharm 1989, 15:1523–1554.
90 du Plessis, J, Ramachandran, C, Weiner, N, Müller, DG. The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 1994, 103:277–282.
91 Verma, DD, Verma, S, Blume, G, Fahr, A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258;141–151.
92 Coderch, L, de Pera, M, Perez‐Cullell, N, Estelrich, J, de la Maza, A, Parra, JL. The effect of liposomes on skin barrier structure. Skin Pharmacol Appl Skin Physiol 1999, 12:235–246.
93 Cevc, , G, Blume, G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992, 1104:226–232.
94 Cevc, G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996, 13:257–388.
95 Cevc, G, Blume, G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 2001, 1514:191–205.
96 Choi, MJ, Maibach, HI. Elastic vesicles as topical/ transdermal drug delivery systems. Int J Cosmet Sci 2005, 27:211–221.
97 Van den Bergh, BAI, Vroom, J, Gerritsen, H, Junginger, HE, Bouwstra, JA. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two photon excitation microscopy. Biochim Biophys Acta 1999, 1461:155–173.
98 Honeywell‐Nguyen, PL, Frederik, PM, Bomans, PHH, Junginger, HE, Bouwstra, JA. Transdermal delivery of pergolide from surfactant‐based elastic and rigid vesicles: characterization and
in vitro transport studies. Pharm Res 2002, 19:991–997.
99 Honeywell‐Nguyen, PL, Bouwstra, JA. The
in vitro transport of pergolide from surfactant‐based elastic vesicles through human skin: a suggested mechanism of action. J Control Release 2003, 86:145–156.
100 Honeywell‐Nguyen, PL, Wouter Groenink, HW, de Graaff, AM, Bouwstra, JA. The
in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release 2003, 90:243–255.
101 Mavon, A, Zahouani, H, Redoules, D, Agache, P, Gall, Y, Humbert, Ph. Sebum and
stratum corneum lipids increase human skin surface free energy as determined from contact angle measurements: a study on two anatomical sites. Colloids Surf B Biointerfaces 1997, 8:147–155.
102 Kuo, T‐R, Wu, C‐L, Hsu, C‐T, Lo, W, Chiang, S‐J, Lin, S‐J, Dong, C‐Y, Chen, C‐C. Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 2009, 30:3002–3008.
103 Nohynek, GJ, Dufour, EK, Roberts, MS. Nanotechnology, cosmetics and the skin: Is there a health risk? Skin Pharmacol Physiol 2008, 21:136–149.
104 Monteiro‐Riviere, NA, Riviere, JE. Interaction of nanomaterials with skin: aspects of absorption and biodistribution. Nanotoxicology 2009, 3:188–193.
105 Monteiro‐Riviere, NA, Baroli, B. %22Nanomaterial penetration.%22 In: Monteiro‐Riviere, NA, ed. Toxicology of the Skin. Chap. 22. Target Organ Toxicology Series. New York:
Informa Healthcare; 2010, 333–346.
.jpg)
.jpg)
